Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia

SNTI Stock  USD 2.14  0.03  1.42%   
Under 51% of Senti Biosciences' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that some traders are interested. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
  
Preclinical data demonstrates the potential for improved treatment outcomes and reduced toxicity for patients with AML Data supports the design of Phase 1 clinical trial of SENTI-202 with patient dosing anticipated in the second quarter of 2024 SOUTH SAN FRANCISCO, Calif., April 30, 2024 -- Senti Biosciences, Inc. , a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ann

Read at finance.yahoo.com
Yahoo News
  

Senti Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Senti Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Senti Biosciences Fundamental Analysis

We analyze Senti Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Senti Biosciences is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Senti Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Senti Biosciences stock to make a market-neutral strategy. Peer analysis of Senti Biosciences could also be used in its relative valuation, which is a method of valuing Senti Biosciences by comparing valuation metrics with similar companies.

Peers

Senti Biosciences Related Equities

RAPTRAPT Therapeutics   9.82   
0%
100.0%
MNPRMonopar Therapeutics   6.43   
0%
65.0%
LIPOLipella Pharmaceuticals   5.36   
0%
54.0%
MLYSMineralys Therapeutics,   4.71   
0%
47.0%
FHTXFoghorn Therapeutics   3.59   
0%
36.0%
CVKDCadrenal Therapeutics,   3.21   
0%
32.0%
XLOXilio Development   2.02   
0%
20.0%
TYRATyra Biosciences   1.78   
0%
18.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
17.0%
FENCFennec Pharmaceuticals   0.50   
5.0%
0%
SABSSAB Biotherapeutics   0.67   
6.0%
0%
CNTBConnect Biopharma   0.97   
9.0%
0%
CINGCingulate   3.67   
37.0%
0%

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios